M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.
Michal HenslerLenka KasikovaKarel FiserJana RakovaPetr SkapaJan LacoTereza LanickovaLadislav PecenIva TruxovaSarka VosahlikovaIrena MoserovaIvan PraznovecVit DrochytekMartina RehackovaTomas BrtnickyLukas RobVladimir BenesJelena PistolicLudek SojkaAles RyskaCatherine Sautès-FridmanWolf Herve FridmanLorenzo GalluzziRadek SpisekJitka FucikovaPublished in: Journal for immunotherapy of cancer (2021)
Immunosuppressive M2-like TAM infiltrating metastatic sites limit clinically relevant immune responses against HGSCs.